Turnover of free and conjugated serum catecholamines during hemodialysis

Insights

Uremic patients on hemodialysis show altered catecholamine levels, with higher free norepinephrine and epinephrine before treatment. Hemodialysis significantly reduces conjugated catecholamines, potentially impairing responses to posture changes.

Area of Science:

  • Nephrology
  • Endocrinology
  • Physiology

Background:

  • Uremia and chronic hemodialysis (HD) can affect the neuroendocrine system.
  • The catecholaminergic system's response in uremic patients undergoing HD requires further investigation.

Purpose of the Study:

  • To evaluate the catecholaminergic system's response in uremic patients undergoing chronic hemodialysis.
  • To compare catecholamine levels and responses to stimuli between uremic patients and healthy individuals.

Main Methods:

  • Serum concentrations of free and conjugated catecholamines (dopamine, norepinephrine, epinephrine) were measured.
  • Measurements were taken before and after hemodialysis.
  • Patients and healthy individuals were subjected to upright posture challenges.

Main Results:

  • Before HD, uremic patients had higher serum levels of free norepinephrine and epinephrine compared to normal individuals.
  • Markedly elevated conjugated catecholamine levels were observed in uremic patients before HD.
  • Hemodialysis led to a significant decrease in conjugated catecholamines and an increase in free norepinephrine, but potentially depleted free catecholamine stores.

Conclusions:

  • Uremic patients exhibit altered baseline catecholamine levels and responses to hemodialysis.
  • The substantial reduction in conjugated catecholamines during HD may impair the catecholaminergic system's ability to respond to postural changes post-treatment.

Related Concept Videos

Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...